GEAR

• Develop optimized viral vectors to facilitate the delivery of retinal gene therapies.

‍

• Creation of high-performance AAV vectors for retinal gene therapy.
• Acceleration of the discovery-to-application cycle thanks to structured data management and AI tools.
• Development of scalable and reproducible workflows for the design of gene therapy solutions in ophthalmology.

‍

• Limited effectiveness of existing AAV vectors in targeting photoreceptors.
• Complex collaboration between researchers in experimental (wet lab) and computational (dry lab) laboratories.
• High costs and inefficiency of traditional AAV development approaches based on random designs.

‍

• Deploy a collaborative workspace to structure and manage all multi-omics and analytics data.
• Ensure traceability and reproducibility of experimental and computational processes.
• Provide analytical tools and pipelines integrating wet lab and in silico approaches.

‍